Mammalian Expression Vector Design Checklist: Critical Verification Steps Before Cloning

A mammalian expression vector design checklist is the systematic verification of every element of an expression construct — promoter, Kozak sequence, signal peptide, gene of interest, fusion tags, selection marker, and poly(A) signal — before ordering the construct or starting cloning. For mammalian protein expression, where constructs are often large (8-12 kb) and cloning cycles are long, in silico verification prior to bench work prevents weeks-long delays from frameshift errors, missing regulatory elements, or incompatible selection strategies.

This checklist covers the essential verification points for mammalian expression vector design, from regulatory elements through tag placement to selection strategy.

Regulatory Element Verification

• Promoter selection: Is the promoter appropriate for the target cell line? CMV for high-level transient expression in HEK293 and CHO cells; EF1α or PGK for more stable, moderate expression; tissue-specific promoters if expression must be restricted. Verify the promoter sequence is complete and in the correct orientation relative to the gene of interest.
• Kozak sequence: The optimal Kozak sequence for mammalian translation initiation is GCCGCC(A/G)CCATGG, with the ATG start codon embedded. Verify that the Kozak sequence is present and matches the consensus. A suboptimal Kozak sequence can reduce translation efficiency 5-10 fold. Check that the ATG within the Kozak is in-frame with the gene of interest.
• Poly(A) signal: The construct must include a polyadenylation signal — typically SV40 poly(A), bGH poly(A), or TK poly(A). Verify the signal sequence is complete and correctly positioned after the gene and any C-terminal tags. A missing or truncated poly(A) signal leads to rapid mRNA degradation and minimal protein expression.

Reading Frame and Tag Placement

• Start-to-finish translation: Translate the full expression cassette in silico (Kozak → signal peptide → tag → gene → tag → stop codon) and verify the amino acid sequence matches expectations. Check that no unexpected stop codons appear before the intended termination codon, and that the final protein sequence includes all intended domains in the correct order.
• Signal peptide processing: If the construct includes a signal peptide for secretion, verify the predicted cleavage site using SignalP or similar tools. An incorrectly predicted cleavage site can result in the mature protein retaining N-terminal signal peptide residues or losing N-terminal amino acids of the protein of interest.
• Tag accessibility: For purification or detection tags (His, FLAG, HA, GFP), verify the tag is in the correct reading frame and positioned so it will be accessible — N-terminal tags should be after the signal peptide (which is cleaved), and C-terminal tags should be before the stop codon. A tag placed after the stop codon will not be translated.

Selection Strategy

• Antibiotic selection marker: The vector should include a mammalian selection marker (neomycin/G418, puromycin, hygromycin, blasticidin, zeocin) driven by a compatible promoter (SV40, PGK). Verify the marker is functional: the complete coding sequence, promoter, and poly(A) signal must all be present.
• Transient vs. stable selection: For transient expression (harvest 48-72h post-transfection), the selection marker may not be needed. For stable cell line generation, the marker is essential and should be tested for kill curve optimization in the target cell line. Confirm that the antibiotic you plan to use matches the resistance marker in the vector — switching them after construct delivery causes avoidable delays.

FAQ

What is the most common error in mammalian expression vector design?

A frameshift at the junction between the signal peptide (or tag) and the gene of interest. Many signal peptides and tags are added via PCR with primers that introduce restriction sites or overhangs; a one- or two-base error in primer design shifts the entire downstream coding sequence out of frame. The resulting protein is truncated or contains an incorrect sequence. Translating the full expression cassette in silico — not just checking the gene alone — catches this before ordering.

How do I verify that the Kozak sequence is optimized for my expression construct?

The consensus Kozak sequence is GCCGCC(A/G)CCATGG. Check that your construct matches this at the critical positions: a purine (A or G) at −3 (three bases upstream of the ATG) and a G at +4 (immediately after the ATG). Position −3 is the most important — a pyrimidine (C or T) at this position can reduce translation by 5-10 fold. Some genes express adequately with suboptimal Kozak sequences; if expression is low, improving the Kozak is one of the first troubleshooting steps.

Conclusion

Mammalian expression vector design verification — checking promoters, Kozak sequences, reading frames across all junctions, tag accessibility, signal peptide processing, and selection marker compatibility — prevents the most common causes of failed expression experiments. Run the full translation in silico before ordering, and have a colleague review the construct map independently. Explore ZettaGene's expression vector design and verification tools for research teams building validated mammalian expression constructs.